AnaptysBio, Inc. Forecast, price target & analysts
AnaptysBio, Inc. Target price 2025 - Analyst rating & recommendation
AnaptysBio, Inc. Classifications & Recommendation:
AnaptysBio, Inc. Price Target
| Target Price | $60.18 |
| Price | $33.56 |
| Potential |
79.32%
register free of charge
|
| Number of Estimates | 14 |
|
14 Analysts have issued a price target AnaptysBio, Inc. 2026 .
The average AnaptysBio, Inc. target price is $60.18.
This is
79.32%
register free of charge
$94.50
181.59%
register free of charge
$20.20
39.81%
register free of charge
|
|
| A rating was issued by 19 analysts: 16 Analysts recommend AnaptysBio, Inc. to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the AnaptysBio, Inc. stock has an average upside potential 2026 of
79.32%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 91.28 | 125.53 |
| 431.93% | 37.52% | |
| EBITDA Margin | -125.26% | -64.92% |
| 86.26% | 48.17% | |
| Net Margin | -159.10% | -93.43% |
| 83.31% | 41.28% |
13 Analysts have issued a sales forecast AnaptysBio, Inc. 2025 . The average AnaptysBio, Inc. sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an AnaptysBio, Inc. EBITDA forecast 2025. The average AnaptysBio, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
13 AnaptysBio, Inc. Analysts have issued a net profit forecast 2025. The average AnaptysBio, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -5.12 | -4.25 |
| 15.79% | 16.99% | |
| P/E | negative | |
| EV/Sales | 5.42 |
13 Analysts have issued a AnaptysBio, Inc. forecast for earnings per share. The average AnaptysBio, Inc. EPS is
This results in the following potential growth metrics and future valuations:
AnaptysBio, Inc....
Current AnaptysBio, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Truist Securities |
Locked
➜
Locked
|
Locked | Nov 10 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Nov 05 2025 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Nov 05 2025 |
| Stifel |
Locked
➜
Locked
|
Locked | Oct 29 2025 |
| Wedbush |
Locked
➜
Locked
|
Locked | Oct 15 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Oct 13 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 30 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Truist Securities:
Locked
➜
Locked
|
Nov 10 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Nov 05 2025 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Nov 05 2025 |
|
Locked
Stifel:
Locked
➜
Locked
|
Oct 29 2025 |
|
Locked
Wedbush:
Locked
➜
Locked
|
Oct 15 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Oct 13 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 30 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
